|
|
 |
|
Viewing report
|
|
|
|
Booming Pharma Sector in India
RNCOS E-Services Private Limited, Aug 2008, Pages: 100
1. Analyst View
2. Global Pharmaceutical Market
3. India - The Emerging Market
4. India - Macroeconomic & Healthcare Profile
4.1 Macroeconomic Profile
4.2 Population Profile
4.3 Healthcare Profile
5. Indian Pharmaceutical Market
5.1 Turnover
5.2 Trade
5.2.1 Export
5.2.2 Import
5.3 Bulk Drugs & Formulations
6. Domestic Pharmaceutical Market
6.1 What Makes the Market so Lucrative?
6.1.1 Ageing Population
6.1.2 Increasing Income
6.1.3 Product Patent Regime
6.1.4 Medical Infrastructure
6.1.5 Prevalence of Lifestyle-related Diseases
6.2 Market Size
6.3 Market Segmentation
6.3.1 By Drugs
6.3.1.1 Traditional Branded Generics
6.3.1.2 Specialty Branded Generics
6.3.1.3 Generic Generics
6.3.1.4 Patented Drugs
6.3.2 By Therapeutics
6.3.2.1 Acute Segment
6.3.2.1.1 Anti-infectives
6.3.2.1.2 Gastrointestinal
6.3.2.1.3 Vitamins/Minerals/Nutrients
6.3.2.1.4 Pain/Analgesics
6.3.2.1.5 Dermatology
6.3.2.1.6 Gynecology
6.3.2.1.7 Respiratory
6.3.2.2 Chronic Segment
6.3.2.2.1 Cardiac
6.3.2.2.2 Neuro/CNS
6.3.2.2.3 Anti-diabetic
6.4 Market Structure
6.5 Key Players
6.6 Future Outlook
6.6.1 Market Drivers & Restraints
6.6.2 Sales (2008-09 to 2011-12)
7. Government Regulations & Market Entry
7.1 Industrial & Manufacturing License
7.2 Patent Laws
7.3 Research & Development
7.4 Pricing
7.5 Market Entry
8. Opportunities
8.1 Biogenerics
8.2 Rural Markets
8.3 Pharma Outsourcing Market
8.4 Bioinformatics
8.5 Health Insurance
8.6 Drug Delivery & Packaging Industry
8.7 Pharmaceutical Retail Chains
9. Roadblocks
9.1 Lack of Innovation
9.2 Drug Price Controls & Low Margins
9.3 Low Per Capita Spending on Drugs
9.4 Multinationals Reluctant to Invest in India
9.5 Counterfeit Drugs
9.6 Government Financing
10. Profile of Key Players
10.1 Ranbaxy Laboratories Limited
10.2 Cipla Limited
10.3 GlaxoSmithKline Pharmaceuticals Limited
10.4 Nicholas Piramal India Limited
10.5 Zydus Cadila
List of Tables
Table 2-1: Global - Market Share & Growth of Leading Therapy Classes (%), 2006
Table 2-2: Global - Pharmaceutical Market by Region (in Billion US$), 2007
Table 5-1: India - Pharmaceutical Exports to Top Countries (in Million US$), 2003-2005
Table 5-2: India - Pharmaceutical Imports from Top Countries (in Million US$), 2003-2005
Table 6-1: India - Top 20 Pharmaceutical Companies by Retail Sales (in Million INR), 2006
Table 6-2: India - Top 20 Pharmaceutical Companies by Retail Sales (in Million INR), 2007
Table 7-1: India - Launch of Patented Drugs by Product & Company
Table 8-1: India - Number of Drug Delivery Companies by Formulation Type (1999, 2003 & 2007E)
Table 8-2: India - Expansion Plans of Pharmacy Retail Chains
Table 9-1: India - Counterfeit Drugs in Domestic Pharmaceutical Market
List of Figures
Figure 2-1: Global - Pharmaceutical Market (in Billion US$), 2002, 2006, 2007 & 2012F
Figure 3-1: Global - Top Pharmaceutical Markets (in Billion US$), 2005
Figure 3-2: Global - Forecast for Top Pharmaceutical Markets (in Billion US$), 2015
Figure 3-3: Global - CAGR of Top Pharmaceutical Markets (%), 2005 to 2015
Figure 4-1: India - Nominal GDP (in Billion US$), 2001-2007
Figure 4-2: India - Forecast for Nominal GDP (in Billion US$) 2008*-2011
Figure 4-3: India - Consumer Price Index (%), 2001-2007
Figure 4-4: India - Forecast for Consumer Price Index (%), 2008*-2011
Figure 4-5: India - Total FDI (in Billion US$), 2002-03 to 2007-08
Figure 4-6: India - FDI in Pharmaceutical Sector (in Million US$), 2003-04 to 2006-07
Figure 4-7: India - Population (in Billion), 2003-2007
Figure 4-8: India - Forecast for Population (in Billion), 2008*-2011
Figure 4-9: India - Population by Gender (%), 2003-2006
Figure 4-10: India - Population Breakup by Age (%), 2003-2007
Figure 4-11: India - Forecast for Population Breakup by Age (%), 2008*-2011
Figure 4-12: India - Per Head Healthcare Spending (in US$), 2001-2007
Figure 4-13: India - Forecast for Per Head Healthcare Spending (in US$), 2008*-2011
Figure 4-14: India - Healthcare Payments by Source (%), 2006
Figure 4-15: India - Number of Doctors (in ‘000) 2005-2007E
Figure 4-16: India - Forecast for Number of Doctors (in ‘000), 2008-2011
Figure 4-17: India - Number of Nurses (in ‘000), 2004-2007E
Figure 4-18: India - Forecast for Number of Nurses (in ‘000), 2008-2011
Figure 4-19: India - Number of Hospital Beds (in ‘000), 2004-2007E
Figure 4-20: India - Forecast for Number of Hospital Beds (in ‘000), 2008-2011
Figure 4-21: India - Number of Deaths due to Leading Causes (in ‘000), 2005
Figure 4-22: India - Leading Causes of Death (%), 2005
Figure 4-23: India - Forecast for Leading Causes of Death (%), 2030
Figure 5-1: India - Pharmaceutical Market Turnover* (in Billion INR), 2001-02 to 2007-08
Figure 5-2: India - Breakup of Pharmaceutical Market (%), 2007-08
Figure 5-3: India - Pharmaceutical Exports (in Billion INR), 2000-01 to 2007-08
Figure 5-4: India - Major API Exports (in Billion INR), 2005-06
Figure 5-5: India - Major Dosage Form Exports (in Billion INR), 2005-06
Figure 5-6: India - Pharmaceutical Exports by Region (%), 2005-06
Figure 5-7: India - Forecast for Pharmaceutical Exports (in Billion INR), 2008-09 to 2011-12
Figure 5-8: India - Pharmaceutical Imports (in Billion INR), 2000-01 to 2007-08E
Figure 5-9: India - Pharmaceutical Imports by Group (%), 2005
Figure 5-10: India - Bulk Drugs Production* (in Billion INR), 2001-02 to 2007-08E
Figure 5-11: India - Formulations Production* (in Billion INR), 2001-02 to 2007-08E
Figure 6-1: India - Population of People above 65 Years (in Million), 2003-2007E
Figure 6-2: India - Income Distribution among Households (%), 1989-90, 2001-02 & 2006-07E
Figure 6-3: India - Prevalence of Lifestyle-related Diseases (%), 2005
Figure 6-4: India - Share of Mass & Specialty Therapies in Pharmaceutical Market (%), 2004, 2006 & 2015F
Figure 6-5: India - Domestic Pharmaceutical Market* (in Billion INR), 2001-02 to 2007-08
Figure 6-6: India - Domestic Pharmaceutical Market by Drug Category (%), 2004
Figure 6-7: India - Forecast for Domestic Pharmaceutical Market by Drug Category (%), 2010
Figure 6-8: India - Traditional Branded Generics Market (in Billion US$), 2004 & 2010F
Figure 6-9: India - Specialty Branded Generics Market (in Billion US$), 2004 & 2010F
Figure 6-10: India - Generic Generics Market (in Billion US$), 2004 & 2010F
Figure 6-11: India - Patented Drugs Market (in Billion US$), 2004 & 2010F
Figure 6-12: India - Domestic Pharmaceutical Market by Therapeutic Category (%), 2007
Figure 6-13: India - CAGR Growth of Major Therapeutic Categories (%), 2007 to 2011
Figure 6-14: India - Anti-infectives Market (in Billion INR), 2006, 2007 & 2011F
Figure 6-15: India - Gastrointestinal Drugs Market (in Billion INR), 2006, 2007 & 2011F
Figure 6-16: India - Vitamins/Minerals/Nutrients Market (in Billion INR), 2006, 2007 & 2011F
Figure 6-17: India - Pain/Analgesics Market (in Billion INR), 2006, 2007 & 2011F
Figure 6-18: India - Dermatology Market (in Billion INR), 2006, 2007 & 2011F
Figure 6-19: India - Gynecology Market (in Billion INR), 2006, 2007 & 2011F
Figure 6-20: India - Number of Asthma Patients (in Million), 2005 & 2015F
Figure 6-21: India - Respiratory Drugs Market (in Billion INR), 2006, 2007 & 2011F
Figure 6-22: India - Number of Coronary Heart Patients (in Million), 2005 & 2015F
Figure 6-23: India - Cardiac Drugs Market (in Billion INR), 2006, 2007 & 2011F
Figure 6-24: India - Neuro/CNS Drugs Market (in Billion INR), 2006, 2007 & 2011F
Figure 6-25: India - Number of Diabetes Patients (in Million), 2005 & 2015F
Figure 6-26: India - Diabetes Market (in Billion INR), 2006, 2007 & 2011F
Figure 6-27: India - Share of Companies in Pharmaceutical Market (%), 2006
Figure 6-28: India - Income Distribution among Households (%), 2006-07* & 2011-12F
Figure 6-29: India - Forecast for Prevalence of Lifestyle-related Diseases (%), 2015
Figure 6-30: India - Forecast for Population of People above 65 Years (in Million), 2008-2011
Figure 6-31: India - Forecast for Domestic Pharmaceutical Market* (in Billion INR), 2008-09 to 2011-12
Figure 8-1: Global - Biogenerics Market (in Million US$), 2006 & 2011F
Figure 8-2: India - Pharmaceutical Market by Geographical Tier (%), 2005
Figure 8-3: India - Forecast for Pharmaceutical Market by Geographical Tier (%), 2011
Figure 8-4: India - Pharma Outsourcing Market (in Million US$), 2004, 2006 & 2007E
Figure 8-5: India - Pharma Outsourcing Market by Segment (%), 2006
Figure 8-6: India - Forecast for Pharma Outsourcing Market (in Million US$), 2008-2011
Figure 8-7: India - Forecast for Pharma Outsourcing Market by Segment (%), 2011
Figure 8-8: India - Bioinformatics Market (in Million US$), 2002-03 to 2006-07 & 2011-12F
Figure 8-9: India - Health Insurance Market (in Billion INR), 2001-02, 2006-07 & 2011-12F
Figure 8-10: India - Drug Packaging Market (in Billion INR), 2006-07* & 2011-12F
Figure 9-1: India & Global - Proportion of Revenue Spent on R&D (%), 2005
Figure 9-2: India - Spending on R&D (in Million US$), 2000-01 to 2005-06
Figure 9-3: Global - Per Capita Drug Consumption in Top Pharmaceutical Markets (in US$), 2006
Figure 9-4: Global - Share of State & Personal Financing in Top Pharmaceutical Markets (%), 2006
Customers who bought this item also bought
Booming Clinical Trials Market in India
Indian Laboratory Analytical Instruments Markets
Booming US Generic Drug Market
China Pharma Outsourcing Annual Review 2009
China Healthcare Sector Analysis
Pharmaceutical Industry in Denmark
Pharmaceutical Industry in Taiwan
Pharmaceutical Industry in South Korea
China Pharmaceuticals and Healthcare Report Q4 2009
Pharmaceutical Industry in Japan
Pharmaceutical Industry in Brazil
Biotech Life Sciences: A 20/20 Vision to 2020
|
|
|
|
